Optive Gel Drops | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Treatment of Dry Eye-Clinical Study 11193X-001: Study 11193X-001 was conducted to evaluate Optive Gel Drops (11193X) in comparison with Celluvisc MD for dry eye. A total of 94 patients received Optive Gel Drops and 94 patients received Celluvisc MD. In this study, most adverse reactions were ocular and mild in severity. The following table presents the most frequent adverse reactions reported for at least 2% of subjects receiving Optive Gel Drops. (See table.)

Click on icon to see table/diagram/image

Postmarketing Experience: The following additional adverse reactions have been identified during postmarketing use of Optive Gel Drops in clinical practice. Because postmarketing reporting of these reactions is voluntary and from a population of uncertain size, it is not always possible to reliably estimate the frequency of these reactions.
Eye disorders: Eye discharge, eye irritation, eyelid edema, foreign body sensation in eyes, lacrimation increased, eye swelling.
Immune System Disorders: Hypersensitivity.

View ADR Reporting Link

Optive Gel Drops Adverse Reactions

Manufacturer:

AbbVie

Distributor:

DKSH